NISA INVESTMENT ADVISORS, LLC - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 135 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 1.3%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$14,000
+40.0%
4100.0%0.00%
Q1 2021$10,000
-16.7%
4100.0%0.00%
Q4 2020$12,000
+71.4%
410
+13.9%
0.00%
Q3 2020$7,000
-36.4%
3600.0%0.00%
Q2 2020$11,000
-96.0%
360
-93.9%
0.00%
-100.0%
Q4 2019$278,0005,9000.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q2 2020
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders